Prophylactic Hepatitis B Virus Vaccines Market to Witness a Pronounce Growth During 2016-2024
Request to Sample of Report @ https://www.persistencemarketresearch.com/samples/10571
The prophylactic hepatitis B virus vaccines market is expected to grow remarkably during the forecast period due to increasing prevalence and incidence of hepatitis B infection, increasing public awareness (Patient Education Programs), government initiatives for promotion and creating awareness about prophylactic hepatitis B vaccines. However, factors such as side effects of the vaccine, high costs incurred during research and development and macro-economic factors like stringent regulations can affect the market adversely.
The global prophylactic hepatitis b virus vaccines market is classified on the basis of end use and geography.
Based on end use, the global prophylactic hepatitis B virus vaccines market is divided into following:
Hospitals & Clinics.
Ever since 1982, vaccines were available for prevention of hepatitis B viral infections and currently more than 1 Bn doses of HBV vaccines have been distributed worldwide. The WHO recommends that all infants should receive the hepatitis B vaccine within 24 hours of birth. Thus, increase in the population base in APAC is expected to contribute significantly to the growth of global prophylactic hepatitis B virus vaccines market.
Geographically, the global prophylactic hepatitis b virus vaccines market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global prophylactic hepatitis B virus vaccines market followed by APAC and Europe. According to WHO, globally more than 240 Mn people suffer from chronic hepatitis B viral infection and about 780,000 people die every year due to consequences related with HBV infection. Of these majority of people belong to developing nations of APAC, Latin America and Africa. The prevalence is considerably low in countries with high level of living standards such as the U.S., Canada, U.K., France, Germany, Italy and Spain.
Some of the major players operating in the market for prophylactic hepatitis B virus vaccines are Merck & Co, Inc., Sanofi Pasteur, Novartis AG, Pfizer Inc., GlaxoSmithKline to name a few. Vaccine market is an oligopolistic market in which the major players such as GlaxoSmithKline, Merck & Co, Inc. and Sanofi Pasteur are using cost leadership and differentiating strategy. The strategy of the major companies in the global prophylactic hepatitis B virus vaccines market is to cut down the prices owing to the increased demand.
Request Report for Table of Contents @ https://www.persistencemarketresearch.com/toc/10571
• Shifting Industry dynamics
• In-depth market segmentation
• Historical, current and projected industry size Recent industry trends
• Key Competition landscape
• Strategies of key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance
Request to Report Methodology @ https://www.persistencemarketresearch.com/methodology/10571
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prophylactic Hepatitis B Virus Vaccines Market to Witness a Pronounce Growth During 2016-2024 here
News-ID: 1059267 • Views: 138
More Releases from Persistence Market Research pvt ltd
Osteoarthritis Treatment Market Analysis By 2025 | Top Key Players are Johnson & …
Persistence Market Research (PMR) has published a new research report on the osteoarthritis treatment market titled “Osteoarthritis Treatment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025).” An alarming rise in the number of osteoarthritis cases is the result of a growing geriatric population worldwide. In order to cater to the needs of the rapidly increasing geriatric population as well as the female population – given that osteoarthritis prevails mostly among
Soft Tissue Repair Market Opportunity By 2024 | Top Key Players are Baxter, B. B …
Soft tissue repair is a process of replacement of destroyed or injured tissue by healthy tissue. One of the key factors driving the market is the rise in a number of accidents and accidental injuries. This is leading to the soft tissue injuries in ligaments, muscle, and tendons. Soft tissue injuries are being treated with soft tissue fixation devices and scaffolds. Increasing number of sports injuries is also driving the
Biosensor Market Forecast By 2020 | Top Key Players are Abbott Laboratories, Inc …
According to a new market report published by Persistence Market Research “Global Market Study on Biosensor: Asia-Pacific to Witness Highest Growth by 2020,” the global biosensor market was valued at USD 12,963.6 million in 2014 and is expected to grow at a CAGR of 9.7% from 2014 to 2020, to reach an estimated value of USD 22,551.2 million in 2020. To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/3589 Globally, the
Growing Usage in Non-medical Sectors to Create Promising Prospects for Medical & …
Persistence Market Research has estimated the global market for medical & industrial gloves at US$ 12,868.6 Mn by the end of 2026, exhibiting robust expansion at a CAGR of 7.9% over 2018–2026. According to the latest market outlook released by the company, the global Medical & Industrial Gloves Market holds promising growth prospects over the next eight years. The market will benefit from multiple innovations through intense research and
More Releases for Hepatitis
Hepatitis E Therapeutics Pipeline Analysis 2018
Hepatitis E is a liver disease caused by infection due to a virus known as hepatitis E virus (HEV). This disease can cause swelling in liver. Some of the common symptoms are mild fever, feeling of tiredness, feeling sick to stomach, and belly pain. Download the sample report at: https://www.pharmaproff.com/request-sample/1029 The World Health Organization (WHO) estimates released in 2018 stated that, every year, an estimated 20 million HEV infections worldwide, leading to
Hepatitis Drugs Market Opportunity Assessment Study
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market The increasing incidences of various types of hepatitis, such as hepatitis B, and hepatitis C are playing a pivotal role in
Global Hepatitis A Vaccine Sales Market Report
In this report, the global Hepatitis A Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Hepatitis A Vaccine for these regions, from 2013
Hepatitis B Vaccines Market Growth Analysis 2021
Hepatitis B refers to an infectious disease that is caused by hepatitis B virus. Symptoms of this disease are not visible in initial stages and develop after few weeks only. Hepatitis B virus is transmitted by exposure to infectious blood or body fluids of an infected person. This disease may even occur from the birth. Hepatitis B may be caused by blood transfusions, healthcare setting, sharing razors and dialysis. Hepatitis
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Global Hepatitis C Drug Sales Market 2017
In this report, the Global Hepatitis C Drug Market 2017 is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Hepatitis C Drug for these regions, from 2012